Powered by Lexis+®
Jurisdiction(s):
United Kingdom
CASE STUDY

“We have to become more agile as our clients' expectations and requirements change. The only thing we know is that tomorrow is going to be different and we must be prepared. With LexisNexis, I feel more confident of that we're ready every time.”

Wolverhampton County Council

Access all documents on Acute exposure

Acute exposure meaning

Published by a LexisNexis Energy expert
What does Acute exposure mean?
In legal practice, acute exposure describes a single, short-duration event (typically under 24 hours) in which a person is exposed to ionising radiation or a toxic substance at a level capable of causing immediate or rapidly developing harm, including severe biological injury or death. It is used to distinguish short‑term, high‑dose incidents from chronic exposure and is central to health and safety compliance, environmental regulation, employer’s liability and personal injury claims, as well as regulatory enforcement. The term is a descriptive scientific expression rather than a defined statutory term. Its meaning is informed by regulatory frameworks such as COSHH, the Ionising Radiations Regulations 2017 (and equivalent Northern Ireland regulations), workplace exposure limits (including short‑term exposure limits) and CLP acute toxicity classifications, and by official guidance used in risk assessment and emergency response. In negligence and breach of statutory duty cases, acute exposure is often addressed through dose reconstruction, monitoring data and expert toxicology or radiology, with temporal proximity assisting causation analysis. Usage is broadly consistent across England & Wales, Scotland, Northern Ireland and Ireland. In Ireland, analogous duties arise under the Safety, Health and Welfare at Work legislation and regulations transposing the Basic Safety Standards Directive on ionising radiation.
Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business–all whilst saving time and reducing risk.

View the related Practice Notes about Acute exposure

PRACTICE NOTES
COVID-19 and UK private M&A: due diligence, valuation, conditionality, MACs, warranties, W&I insurance, TUPE, auctions, execution, stamp duty and Companies House filings

Coronavirus (COVID-19)—impact on private M&A transactions [Archived] ARCHIVED: This archived Practice Note examined how the coronavirus (COVID-19) pandemic affected private M&A (share purchase or asset purchase) deals. It has not been revised since May 2022. Factors affecting deal activity For the duration of the coronavirus (COVID-19) outbreak, many strands of corporate law will be influenced, shaping the work of legal practitioners and their clients. The effects on private M&A transactions are likely to extend beyond the pandemic’s immediate timeframe, given the wider repercussions for the economy and for individual businesses. Direct consequences arising from the pandemic include: financial viability of pursuing an acquisition—amid the economic turmoil and global shock, can buyers access the requisite funds to complete a private M&A deal? A prospective purchaser may prefer to preserve or strengthen cash reserves, rather than hunt for acquisition prospects, as a prudent approach to financial management to withstand the challenges posed by the COVID-19 pandemic heightened transaction risk—concluding a deal during a period of...

Read More Right Arrow